Lymphoma Risk Increases With Hepatitis C
Posted on: Thursday, 10 May 2007, 09:00 CDT
People infected with hepatitis C virus, or HCV, are at an increased risk of developing certain lymphomas, according to U.S. researchers.
Since so much is still unknown about the causes of lymphoma, establishing which factors contribute to the disease is the first step in finding ways to reduce its incidence and lessen mortality, according to the study published in the Journal of the American Medical Association.
Researchers from the National Cancer Institute in Bethesda, Md., and Baylor College of Medicine in Houston found that HCV infection increased the risk of developing non-Hodgkin's lymphoma by 20 percent to 30 percent.
HCV causes hepatitis, or inflammation of the liver. The HCV virus is carried through the blood and is passed from person to person through the exchange of bodily fluids -- via shared needles, open wounds and sexual contact, among other means.
Source: United Press International
Related Articles
- Results of Large HCV Trial Released
- InterMune Presents New Preclinical Data on Its HCV Protease Inhibitor at Digestive Disease Week
- Third Wave, Chiron, Bayer dismiss HCV patent suit
- Hepatitis C Leadership Summit Engages HCV Stakeholders to Elevate the Response to the HCV Epidemic; New Opportunities For Action With Currently-Available Resources
- InterMune Presents HCV Protease Inhibitor Data at AASLD
- Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population
- OraSure Receives HCV Patent License From Ortho-Clinical Diagnostics and Chiron Corporation; OraSure to Develop and Commercialize Rapid HCV Test
- Rigel's Productivity on Track: HCV and R&D Pipeline Update
- ViroPharma Announces Data From HCV-086 Proof of Concept Study
- ViroPharma Announces Start of HCV-796 Phase 1 Program
 |
 |
User Comments (0)
RSS Feeds